• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Envoke

To add a bio or update company history, please click update information.

News from Envoke

    Envoke lands £1.6m from VCs for lab equipment training and maintenance softwareEnvoke lands £1.6m from VCs for lab equipment training and maintenance software
    Envoke
    12 May 2026

    Envoke lands £1.6m from VCs for lab equipment training and maintenance software

    Envoke develops software that creates virtual replicas of laboratory equipment for remote training, troubleshooting and maintenance. The platform helps healthcare providers and equipment manufacturers reduce downtime, improve staff training and cut servicing costs.

    Envoke raises £1m seed extension from Mercia to expand virtual training platform for lab staffEnvoke raises £1m seed extension from Mercia to expand virtual training platform for lab staff
    Envoke
    19 May 2025

    Envoke raises £1m seed extension from Mercia to expand virtual training platform for lab staff

    Envoke builds virtual training software for laboratory equipment, allowing staff to learn, practise and troubleshoot using realistic digital simulations and remote support tools.

Envoke
  • Life Sciences
  • Leeds, United Kingdom
  • £2.6m
  • envoke-demos.com
  • Update Information

More venture news

  • Tolemy Bio secures a £1.2m pre-seed round led by Norrsken Evolve for software that connects fragmented cell biology data into one workspace
    Tolemy Bio
    11 May 2026

    Tolemy Bio secures a £1.2m pre-seed round led by Norrsken Evolve for software that connects fragmented cell biology data into one workspace

    Pre-seedLife Sciences
  • NunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale
    NunaBio
    5 May 2026

    NunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale

    EquityLife Sciences
  • Cytospire Therapeutics secures £61m Series A led by 4BIO Capital for cancer therapies that activate the body’s immune cells
    Cytospire Therapeutics
    5 May 2026

    Cytospire Therapeutics secures £61m Series A led by 4BIO Capital for cancer therapies that activate the body’s immune cells

    Series ALife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn